Companies are pushing ahead with their initial public offerings (IPOs) by compromising on valuations and reducing their issue ...

The FPX ETF, focused on high-growth IPOs, may not be the best investment choice in a high-interest rate environment. Read an analysis here.

There is no word yet on when the IPO will happen. According to Voyager, it is still working out "the number of shares to be ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...